中国老年学杂志
中國老年學雜誌
중국노년학잡지
CHINESE JOURNAL OF GERONTOLOGY
2014年
20期
5671-5672
,共2页
汤虹%王启鸣%赵红星%王莉莉%朱辉%罗素霞
湯虹%王啟鳴%趙紅星%王莉莉%硃輝%囉素霞
탕홍%왕계명%조홍성%왕리리%주휘%라소하
恶性肿瘤%骨转移%骨痛%伊班膦酸钠
噁性腫瘤%骨轉移%骨痛%伊班膦痠鈉
악성종류%골전이%골통%이반련산납
Malignant cancer%Bone metastasis%Bone pain%Ibandronate
目的:观察负荷量伊班膦酸钠治疗恶性肿瘤转移性骨痛的疗效和安全性。方法30例晚期恶性肿瘤骨转移患者,给予负荷量伊班膦酸钠6 mg/d,连续用3 d(共18 mg)。观察并记录止痛起效的时间、疼痛评分、生活质量KPS评分、吗啡日耗量、血钙、碱性磷酸酶和肾功能等的变化。结果治疗后23例患者疼痛缓解,缓解率76.7%,疼痛缓解平均所需时间(4.48±0.28)d,治疗后疼痛评分改善、生活质量评分提高(P<0.01);有7例患者治疗后吗啡每日用量减少20~60 mg。治疗前6例患者血钙增高,治疗后均降至正常范围;不良反应少,未出现肾脏毒性反应。结论伊班膦酸钠负荷量给药止痛起效快,可迅速改善转移性骨痛,减少吗啡用量,提高患者的生活质量,并能有效降低血钙及碱性磷酸酶,疗效显著。
目的:觀察負荷量伊班膦痠鈉治療噁性腫瘤轉移性骨痛的療效和安全性。方法30例晚期噁性腫瘤骨轉移患者,給予負荷量伊班膦痠鈉6 mg/d,連續用3 d(共18 mg)。觀察併記錄止痛起效的時間、疼痛評分、生活質量KPS評分、嗎啡日耗量、血鈣、堿性燐痠酶和腎功能等的變化。結果治療後23例患者疼痛緩解,緩解率76.7%,疼痛緩解平均所需時間(4.48±0.28)d,治療後疼痛評分改善、生活質量評分提高(P<0.01);有7例患者治療後嗎啡每日用量減少20~60 mg。治療前6例患者血鈣增高,治療後均降至正常範圍;不良反應少,未齣現腎髒毒性反應。結論伊班膦痠鈉負荷量給藥止痛起效快,可迅速改善轉移性骨痛,減少嗎啡用量,提高患者的生活質量,併能有效降低血鈣及堿性燐痠酶,療效顯著。
목적:관찰부하량이반련산납치료악성종류전이성골통적료효화안전성。방법30례만기악성종류골전이환자,급여부하량이반련산납6 mg/d,련속용3 d(공18 mg)。관찰병기록지통기효적시간、동통평분、생활질량KPS평분、마배일모량、혈개、감성린산매화신공능등적변화。결과치료후23례환자동통완해,완해솔76.7%,동통완해평균소수시간(4.48±0.28)d,치료후동통평분개선、생활질량평분제고(P<0.01);유7례환자치료후마배매일용량감소20~60 mg。치료전6례환자혈개증고,치료후균강지정상범위;불량반응소,미출현신장독성반응。결론이반련산납부하량급약지통기효쾌,가신속개선전이성골통,감소마배용량,제고환자적생활질량,병능유효강저혈개급감성린산매,료효현저。
Objective To investigate the efficiency and safety of loading dose of ibandronate treating bone metastases of malignant cancer.Methods 30 cases of malignant cancer with bone metastases were analyzed retrospectively.Ibandronate was administered intrave-nously 6 mg for 3 days( total dose of 18 mg ) .The respond time, pain score, QOL score, daily morphine consumption dose were recorded. The serum calcium, alkaline phosphatase ( AKP) and creatinine were monitored.Results After treatment, the rate of pain relief in 23 cases was 76.7%.Their average response time was (4.48±0.28)d.The pain score was significantly decreased after treatment and the life quali-ties of patients were markerly improved (P<0.01 ).The morphine daily comsumption dose was reduced about 20~60 mg in 7 cases after treatment.Hypercalcemia was found in 6 patients before treatment and the serum calcium level was declined to the normal level after treat-ment.Ibandronate was well tolerated with no evidence of renal toxicity.Conclusions Administration of ibandronate loading dose has quick onset and could relieve metastasis bone pain, improve life quality, reduce the consumption of morphine and effectively decrease serum calci-um level, which is worthy of clinical popularization and application.